This is a report concerning human polyomavirus JC (JCV) reactivation in a pediatric patient with Crohn's disease (CD) during the treatment with 5-aminosalicylic acid (5-ASA), a non-steroidal anti-inflammatory drug (NSAID). We examined 9 bioptic samples from three different bowel districts (ileum, cecum, rectum) of this child. These samples were analyzed by Quantitative PCR (Q-PCR) to investigate the presence of JCV DNA. JCV DNA was detected in one rectum biopsy taken two months after 5-ASA treatment. Although our result must be validated in a larger group of subjects and with a longer follow-up period, it underlines the importance of JCV monitoring in CD patients.
SartorRB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol2006; 3:390–407.
2.
BellizziABaruccaVFioritiDColosimoMTMischitelliMAnzivinoEChiariniFPietropaoloV. Early years of biological agents therapy in Crohn's disease and risk of the human polyomavirus JC reactivation. J Cell Physiol2010; 224:316–26.
3.
MayerL. Evolving paradigms in the pathogenesis of IBD. J Gastroenterol2010; 45:9–16.
4.
BosaniMArdizzoneSPorroGB. Biologic targeting in the treatment of inflammatory bowel diseases. Biologics2009; 3:77–97.
5.
RicciardielloLLaghiLRamamirthamPChangCLChangDKRandolphAEBolandCR. JC virus DNA sequences are frequently present in the human upper and lower gastrointestinal tract. Gastroenterology2000; 119:1228–35.
6.
SelgradMDe GiorgioRFiniL. JC Virus Infects the Enteric Glia of Patients with Chronic Idiopathic Intestinal Pseudo-obstruction. Gut2009; 58:25–32.
7.
MaginnisMSAtwoodWJ. JC virus: an oncogenic virus in animals and humans?Semin Cancer Biol2009; 19:261–9.
8.
FrisqueRJHofstetterCTyagarajanSH. Trasforming activities of JC virus early proteins. Adv Exp Med Biol2006; 577:288–309.
9.
WhiteMKGordonJReissKDel ValleLCroulSGiordanoADarbinyanAKhaliliK. Human polyomaviruses and brain tumors. Brain Res Rev2005; 50:69–85.
10.
JungWTLiMSGoelABolandCR. JC virus T-antigen expression in sporadic adenomatous polyps of the colon. Cancer2008; 112:1028–36.
11.
ShinSKLiMSFuerstFHotchkissEMeyerRKimITGoelABolandCR. Oncogenic T-Antigen of JC Virus is present frequently in human gastric cancers. Cancer2006; 107:481–8.
12.
CartyEMacEyMRamptonDS. Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment Pharmacol Ther2000; 14:1169–79.
13.
Van AsscheGVan RanstMSciotR. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med2005; 353:362–8.
14.
VerbeeckJVan AsscheGRydingJ. JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?Gut2008; 57:1393–7.
15.
DelbueSBranchettiEBoldoriniRVagoLZerbiPVeggianiCTremoladaSFerranteP. Presence and expression of JCV early gene large T Antigen in the brains of immunocopromised and immunocompetent individuals. J Med Virol2008; 80:2147–52.
16.
YamamotoYGaynorRB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest2001; 107:135–42.
